• Benzyl-activated Streptavidin Magnetic Beads

  2026-09-16

  Benzyl-activated Streptavidin Magnetic Beads (SKU: K1301) provide magnetic capture of biotinylated proteins, peptides, nucleic acids, and other ligands from complex samples. They are suitable for affinity purification and interaction assays, but not for direct capture of non-biotinylated targets or workflows requiring covalent immobilization.

• Trametinib (GSK1120212): Assay Guide

  2026-09-16

  A scenario-based guide to using Trametinib (GSK1120212), SKU A3018, in cell viability, proliferation, and cytotoxicity workflows. It connects MEK–ERK biology with practical dosing, solvent, genotype, interpretation, and supplier-selection decisions while distinguishing product specifications from workflow recommendations.

• Phosbind Acrylamide for Protein Phosphorylation Analysis

  2026-09-15

  Phosbind Acrylamide converts an ordinary SDS-PAGE workflow into an antibody-free screen for phosphorylation-dependent mobility shifts. This guide explains how to use it for kinase assays, signaling studies, and hypothesis-driven bacterial virulence experiments while clarifying its range, controls, and limitations.

• Benzyl-activated Streptavidin Magnetic Beads K1301

  2026-09-15

  Benzyl-activated Streptavidin Magnetic Beads (SKU: K1301) provide magnetic capture of biotinylated peptides, proteins, antibodies, oligonucleotides, nucleic acids, and other targets from complex samples. They are suitable for purification, immunoprecipitation, interaction studies, and screening workflows, but their BSA-containing, sodium-azide-preserved formulation requires compatibility testing before use with live cells, mass spectrometry, or other sensitive downstream assays.

• Caspase-3 Colorimetric Assay Kit: Practical Guide

  2026-09-14

  The Caspase-3 Colorimetric Assay Kit (SKU K2008) provides a practical plate-reader or spectrophotometer workflow for measuring DEVD-dependent caspase-3 activity in biological lysates. It is suitable for comparative apoptosis assays and pathway studies, but should not be treated as stand-alone proof of apoptosis, isoform-specific activity, or a clinical diagnosis.

• SkQ1 and Ovarian Cancer Muscle Atrophy

  2026-09-14

  This study used a stage-resolved ovarian cancer model to test whether mitochondrial hydrogen peroxide, apoptosis-related caspases, and necroptotic signalling drive skeletal muscle atrophy. SkQ1 normalized late-stage mitochondrial oxidant emission and caspase activity without restoring fibre size, indicating that these pathways may accompany rather than cause type IIB muscle loss.

• Thiazovivin: Practical ROCK Inhibitor Workflow

  2026-09-13

  Thiazovivin is a ROCK inhibitor for research workflows that need better control of cell recovery after dissociation or support during fibroblast reprogramming. This guide covers preparation, controls, and troubleshooting while emphasizing that working concentrations, exposure times, and clinical applications must be established for each cell model rather than inferred from the product dossier.

• FLAG tag Peptide Workflows for Protein Research

  2026-09-12

  Learn how to use the FLAG tag Peptide for gentle recombinant protein capture, elution, detection, and quality control. The workflow is especially useful for structurally sensitive complexes, including DNA polymerase preparations where harsh purification may compromise activity or Fe–S-dependent function.

• Acetylcysteine in 3D PDAC Redox Models

  2026-09-12

  Acetylcysteine can serve as more than a generic antioxidant in pancreatic cancer research. This article shows how N-acetyl-L-cysteine may be used as a carefully controlled redox perturbation in patient-derived organoid–fibroblast assays, while distinguishing evidence from hypothesis.

• Peroxynitrite–Ca2+ Signaling in Cardiac Injury

  2026-09-11

  Liu et al. identify an ONOO−-driven ER stress–IP3R–mitochondrial Ca2+ pathway that links hyperhomocysteinemia to cardiac microvascular endothelial necroptosis during ischemia–reperfusion. The study connects oxidative chemistry with organelle-level calcium mis-handling and shows that IP3R inhibition improves cardiac injury outcomes in hyperhomocysteinemic rats.

• PP2A, Autophagy, and Candida Biofilm Resistance

  2026-09-11

  The reference study identifies PP2A, encoded in part by PPH21, as a regulator of Candida albicans biofilm formation and antifungal resistance through ATG protein phosphorylation and autophagy activation. Its genetic, pharmacologic, cellular, and mouse-model evidence provides a mechanistic framework for studying persistent oral candidiasis, while also defining important limits for translation to other species and infection models.

• Deep Learning for iPSC-CM Cardiotoxicity Screening

  2026-09-10

  Grafton and colleagues combined induced pluripotent stem cell-derived cardiomyocytes, high-content imaging, and deep learning to identify cardiotoxic patterns across chemically diverse libraries. The study shows how a single image-derived score can support early, target-agnostic toxicity triage while also highlighting the need for orthogonal validation and careful transfer across cell models.

• Human Organellar SPFH Complexes: Cryo-EM Insights

  2026-09-10

  Gao and colleagues define the architectures of the human Erlin1/2 and PHB1/2 SPFH complexes using single-particle cryo-EM. Their findings reveal distinct heterodimeric stoichiometries and conformational behavior, providing a structural framework for interpreting organellar membrane organization and protein quality control.

• Verapamil HCl: A Decision Framework for Assays

  2026-09-09

  Verapamil HCl is more than an L-type calcium channel blocker: it is a layered mechanistic probe for calcium signaling, apoptosis, inflammation, and bone remodeling. This assay-focused guide explains how to separate proximal channel effects from downstream TXNIP, stress, and disease-model phenotypes.

• Intravitreal Metformin in CNV and Retinal Degeneration

  2026-09-09

  This preclinical study tested intravitreal metformin across explant, choroidal neovascularization, and light-induced retinal degeneration models. Its main contribution is the demonstration that local metformin treatment can reduce pathological vessel growth, inflammatory cell recruitment, and retinal thinning, while also altering angiogenesis- and inflammation-associated gene expression.

8664 records 1/578 page Next 12345 下5页 Last page